Avidity Partners Management LP Amylyx Pharmaceuticals, Inc. Transaction History

Avidity Partners Management LP

  • $1.63 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$12.07 - $18.46 $20.4 Million - $31.2 Million
-1,692,439 Reduced 96.33%
64,501 $949,000
Q3 2023

Nov 14, 2023
BUY
$18.08 - $23.45 $15.5 Million - $20.1 Million
855,540 Added 94.91%
1,756,940 $32.2 Million
Q2 2023

Aug 14, 2023
BUY
$20.98 - $31.42 $29,372 - $43,988
1,400 Added 0.16%
901,400 $19.4 Million
Q1 2023

May 15, 2023
BUY
$27.71 - $40.93 $24.9 Million - $36.8 Million
900,000 New
900,000 $26.4 Million

Others Institutions Holding AMLX

# of Institutions
127
Shares Held
44.4M
Call Options Held
235K
Put Options Held
530K
View Full List

About Amylyx Pharmaceuticals, Inc.

AMLX Quotes by TradingView
  • Ticker AMLX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,533,200
  • Market Cap $308M
  • Description
  • Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...
More about AMLX
Track This Portfolio

Track Avidity Partners Management LP Portfolio

Follow Avidity Partners Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avidity Partners Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Avidity Partners Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email